Jeffrey C Bemis

Title: The Innovative Contributions of Jeffrey C. Bemis

Introduction

Jeffrey C. Bemis is a notable inventor based in Rochester, NY, who has made significant contributions to the field of biotechnology. With a total of seven patents to his name, he has focused on developing methods and tools that enhance our understanding of DNA damage and its implications.

Latest Patents

Among his latest inventions is the "Simplified nuclei analysis platform and biomarker matrix that supports genotoxic mode of action determinations." This invention presents a straightforward method for evaluating free eukaryotic cell nuclei for biomarkers of DNA damage, transcription factor activation, and epigenetic modifications to chromatin. The invention also outlines effective strategies for combining nuclear biomarkers into a matrix of endpoints, which can elucidate the primary mode of DNA-damaging activity of genotoxicants. Additionally, kits for conducting methods according to this invention are described, showcasing its practical applications.

Career Highlights

Jeffrey C. Bemis is currently associated with Litron Laboratories Ltd., where he continues to innovate and contribute to the field. His work has been instrumental in advancing methodologies that assess genetic damage and its biological consequences.

Collaborations

Throughout his career, Bemis has collaborated with esteemed colleagues such as Stephen D. Dertinger and Steven M. Bryce, further enhancing the impact of his research and inventions.

Conclusion

Jeffrey C. Bemis stands out as a prominent inventor whose work in biotechnology has the potential to significantly influence the understanding of genetic damage and its effects. His innovative patents and collaborations reflect his commitment to advancing scientific knowledge in this critical area.